These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20424239)

  • 21. Medication for schizophrenia.
    Gray R
    Nurs Times; 2001 Aug 2-8; 97(31):38-9. PubMed ID: 11957534
    [No Abstract]   [Full Text] [Related]  

  • 22. Weighing scientific evidence: let's keep the blindfold off.
    Zima BT
    Psychiatr Serv; 2010 Feb; 61(2):107. PubMed ID: 20123812
    [No Abstract]   [Full Text] [Related]  

  • 23. Datapoints: prescription patterns for mood and anxiety disorders in a community sample.
    Mojtabai R
    Psychiatr Serv; 1999 Dec; 50(12):1557. PubMed ID: 10577871
    [No Abstract]   [Full Text] [Related]  

  • 24. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
    Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
    Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variations in prescribing practices for novel antipsychotic medications among Veterans Affairs hospitals.
    Owen RR; Feng W; Thrush CR; Hudson TJ; Austen MA
    Psychiatr Serv; 2001 Nov; 52(11):1523-5. PubMed ID: 11684751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of antipsychotic medications in pediatric populations: what do the data say?
    Penfold RB; Stewart C; Hunkeler EM; Madden JM; Cummings JR; Owen-Smith AA; Rossom RC; Lu CY; Lynch FL; Waitzfelder BE; Coleman KJ; Ahmedani BK; Beck AL; Zeber JE; Simon GE
    Curr Psychiatry Rep; 2013 Dec; 15(12):426. PubMed ID: 24258527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The A+KIDS Program.
    Farley JF; Weeks L; Wegner SE
    Psychiatr Serv; 2013 Jan; 64(1):98-9. PubMed ID: 23280465
    [No Abstract]   [Full Text] [Related]  

  • 28. Best practices: An initiative to curtail the use of antipsychotic polypharmacy in a state psychiatric hospital.
    Patrick V; Schleifer SJ; Nurenberg JR; Gill KJ
    Psychiatr Serv; 2006 Jan; 57(1):21-3. PubMed ID: 16399958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APA targets unnecessary antipsychotic use.
    Kuehn BM
    JAMA; 2013 Nov; 310(18):1909-10. PubMed ID: 24219927
    [No Abstract]   [Full Text] [Related]  

  • 30. Prescribing behavior and marketing practices.
    Stone AM
    Psychiatr Serv; 2006 Mar; 57(3):419; author reply 419. PubMed ID: 16525009
    [No Abstract]   [Full Text] [Related]  

  • 31. The diffusion of innovations into psychiatric practice.
    Freedman J
    Psychiatr Serv; 2002 Dec; 53(12):1539-40. PubMed ID: 12461211
    [No Abstract]   [Full Text] [Related]  

  • 32. Off-label prescribing: in search of a reasonable patient-centered approach.
    Rich BA
    J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):131-3. PubMed ID: 22764850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotic medication prescribing in children enrolled in Medicaid.
    Rettew DC; Greenblatt J; Kamon J; Neal D; Harder V; Wasserman R; Berry P; MacLean CD; Hogue N; McMains W
    Pediatrics; 2015 Apr; 135(4):658-65. PubMed ID: 25733747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Best practices: racial and ethnic effects on antipsychotic prescribing practices in a community mental health center.
    Woods SW; Sullivan MC; Neuse EC; Diaz E; Baker CB; Madonick SH; Griffith EE; Steiner JL
    Psychiatr Serv; 2003 Feb; 54(2):177-9. PubMed ID: 12556597
    [No Abstract]   [Full Text] [Related]  

  • 35. Curbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS).
    Nelson LS; Perrone J
    JAMA; 2012 Aug; 308(5):457-8. PubMed ID: 22851109
    [No Abstract]   [Full Text] [Related]  

  • 36. Reducing Antipsychotic Medications: Developing a Systematic Process.
    McHenry Martin C
    Consult Pharm; 2015 Jul; 30(7):378-84. PubMed ID: 26173189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The challenge of off-label prescribing.
    Phillips J
    Int J Palliat Nurs; 2015 Sep; 21(9):419. PubMed ID: 26412270
    [No Abstract]   [Full Text] [Related]  

  • 38. Off-label use of atypical antipsychotic medications in Canterbury, New Zealand.
    Monasterio E; McKean A
    N Z Med J; 2011 Jun; 124(1336):24-9. PubMed ID: 21946741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotic treatment of adults in the United States.
    Olfson M; King M; Schoenbaum M
    J Clin Psychiatry; 2015 Oct; 76(10):1346-53. PubMed ID: 26528641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reducing metabolic syndrome in Australian patients: Metabolic Management During Antipsychotic Prescribing (MMAP) programme.
    Castle DJ; Hopwood M; Rege S; George DB
    Australas Psychiatry; 2022 Feb; 30(1):84-89. PubMed ID: 33969715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.